Clinical trials
Completed Phase 3 Esophageal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Chinese University of Hong Kong | 2 |
| Federation Francophone de Cancerologie Digestive | 2 |
| Radiation Therapy Oncology Group | 2 |
| University of Oxford | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Cancer Trials Ireland | 1 |
| Centre Oscar Lambret | 1 |
| Ciusss de L'Est de l'Île de Montréal | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 41 |
| Esophageal Squamous Cell Carcinoma | 8 |
| Stomach Neoplasms | 8 |
| Bile Duct Neoplasms | 3 |
| Breast Neoplasms | 3 |
| Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Small Cell Lung Carcinoma | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Squamous Cell | 2 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.